Othera is a pharmaceutical company developing novel therapeutics for age-related diseases of the eye. Othera's lead compound, OT-551 is an eye drop in a Phase II clinical trial for the dry form of macular degeneration (AMD), and recently announced positive interim data from that trial, with full trial results due in mid-2010. The company is also developing novel treatments for glaucoma and neurodegenerative diseases.
Company Details
- Employees
- 30
- Address
- Exton, Pa 19341, Us
- Phone
- 484-879-2800
- in****@****era.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.othera.com
- HQ
- Exton, PA
Othera Pharmaceuticals Questions
Othera Pharmaceuticals's helpline number is 484-879-2800
Othera Pharmaceuticals's website is http://www.othera.com
Othera Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/othera-pharmaceuticals
Othera Pharmaceuticals has
30 employees.
View email and phone details for 30
employees at Othera Pharmaceuticals.
Othera Pharmaceuticals's industry is
Pharmaceutical Manufacturing
Othera Pharmaceuticals's top competitors are
Cytel,
Advarra,
Nuventra Pharma Sciences,
Aqua Pharmaceuticals, An Almirall Company,
Red Nucleus,
Hmp Global,
Still & Moving Center,
Catalent,
Ubc,
Endo.
Othera Pharmaceuticals's support email address is info@othera.com
Othera Pharmaceuticals's categories are Pharmaceutical Manufacturing
